Connection

WILLIAM FISHER to Antineoplastic Agents

This is a "connection" page, showing publications WILLIAM FISHER has written about Antineoplastic Agents.
Connection Strength

0.082
  1. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019 02 01; 442:310-319.
    View in: PubMed
    Score: 0.034
  2. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS One. 2014; 9(9):e106289.
    View in: PubMed
    Score: 0.025
  3. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 2019 02; 165(2):307-314.
    View in: PubMed
    Score: 0.008
  4. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo. Surgery. 1997 Apr; 121(4):392-7.
    View in: PubMed
    Score: 0.008
  5. Biologic effect of neurogenesis in pancreatic cancer. Hum Pathol. 2016 06; 52:182-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.